Los Angeles Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3,667
| Closed | -$1.31M | – | 1137 |
|
2023
Q3 | $1.31M | Sell |
3,667
-10,614
| -74% | -$3.8M | 0.01% | 549 |
|
2023
Q2 | $5.41M | Sell |
14,281
-170,515
| -92% | -$64.6M | 0.02% | 326 |
|
2023
Q1 | $88.5M | Buy |
+184,796
| New | +$88.5M | 0.39% | 61 |
|
2022
Q2 | – | Sell |
-1,885
| Closed | -$1.06M | – | 1331 |
|
2022
Q1 | $1.06M | Sell |
1,885
-7,466
| -80% | -$4.21M | ﹤0.01% | 732 |
|
2021
Q4 | $7.07M | Buy |
9,351
+8,171
| +692% | +$6.17M | 0.03% | 307 |
|
2021
Q3 | $880K | Buy |
+1,180
| New | +$880K | ﹤0.01% | 807 |
|
2021
Q1 | – | Sell |
-860
| Closed | -$501K | – | 1582 |
|
2020
Q4 | $501K | Sell |
860
-40
| -4% | -$23.3K | ﹤0.01% | 1206 |
|
2020
Q3 | $464K | Buy |
900
+40
| +5% | +$20.6K | ﹤0.01% | 1110 |
|
2020
Q2 | $388K | Sell |
860
-880
| -51% | -$397K | ﹤0.01% | 1210 |
|
2020
Q1 | $610K | Sell |
1,740
-70
| -4% | -$24.5K | ﹤0.01% | 845 |
|
2019
Q4 | $670K | Sell |
1,810
-1,809
| -50% | -$670K | ﹤0.01% | 944 |
|
2019
Q3 | $1.2M | Sell |
3,619
-7,324
| -67% | -$2.44M | 0.01% | 760 |
|
2019
Q2 | $3.42M | Buy |
10,943
+1,190
| +12% | +$372K | 0.02% | 526 |
|
2019
Q1 | $2.98M | Buy |
9,753
+5,730
| +142% | +$1.75M | 0.02% | 542 |
|
2018
Q4 | $934K | Sell |
4,023
-3,485
| -46% | -$809K | 0.01% | 765 |
|
2018
Q3 | $2.35M | Sell |
7,508
-26,035
| -78% | -$8.15M | 0.01% | 627 |
|
2018
Q2 | $9.68M | Sell |
33,543
-2,550
| -7% | -$736K | 0.05% | 358 |
|
2018
Q1 | $9.03M | Buy |
36,093
+4,085
| +13% | +$1.02M | 0.05% | 333 |
|
2017
Q4 | $7.64M | Sell |
32,008
-410
| -1% | -$97.9K | 0.04% | 379 |
|
2017
Q3 | $7.2M | Sell |
32,418
-1,076
| -3% | -$239K | 0.04% | 370 |
|
2017
Q2 | $7.58M | Buy |
33,494
+11,635
| +53% | +$2.63M | 0.05% | 369 |
|
2017
Q1 | $4.36M | Buy |
+21,859
| New | +$4.36M | 0.03% | 433 |
|